期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

PET在神经精神疾病领域中的应用进展 被引量：3

The Applications of Positron Emission Tomography in Neurological and Psychiatric Disorders
下载PDF
导出
摘要 PET作为功能性分子成像的主要工具,在帕金森病及阿尔茨海默等神经退行性疾病、精神障碍、脑肿瘤、癫痫、脑血管疾病等方面扮演了重要角色。尽管脑PET显像在神经精神疾病临床应用方面已经取得了长足的进步,但考虑到其独特的功能成像优势和转化医学的发展,PET仍没有发掘出全部潜力。今后脑PET显像可能的发展方向:仪器的发展;新型示踪剂的研究;脑生理激发试验的深入;神经传导通路和神经生理的研究;精神疾病的研究等。 Positron emission tomography （PET） is a major tool for functional molecular imaging and plays an important role in the study of brain function, epilepsy as well as neurodegenerative diseases such as Parkinson＇s disease and Alzheimer＇s disease. However, despite its unique strengths and in view of the present needs in translational experimental medicine, PET is currently not achieving its full potential in brain research and clinical application. In the thture, the potentials of brain PET include development of the instrument, new tracers, further brain physiological provocation test, nerve conduction pathways and neurophysiological studies and mental illness.
作者 张慧玮 左传涛 许震生
机构地区 复旦大学附属华山医院PET中心
出处 《中国医疗器械信息》 2013年第10期1-8,共8页 China Medical Device Information
基金 国家自然科学基金面上项目(81171189 81271516)
关键词 正电子断层显像 阿尔茨海默病 帕金森病 癫痫 精神分裂症 positrc, n emission tomography, alzheimer＇s disease, parkinson＇s disease, epilepsy, schizophrenia
分类号 R817.4 [医药卫生—影像医学与核医学]
  • 相关文献

参考文献21

  • 1Reiman, E.M. and W.J, Jagust, Brain imaging in the study of Alzheimer's disease. Neuroimage, 2012.61(2): p. 505-16.
  • 2Herholz, K., Perfusion SPECT and FDG-PET. Int Psychogeriatr, 2011. 23 Suppl 2: p. $25-31.
  • 3Caroli, A., et al., Summary metrics to assess Alzheimer disease-related hypometabolic pattern with :SF-FDG PET: head-to- head comparison. J Nucl Med, 2012.53(4): p. 592-600.
  • 4Landau, S.M., et al., Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging, 2011.32(7): p. 1207-18.
  • 5Herholz, K., Use of FDG PET as an imaging biomarker in clinical trials of Alzheimer's disease. Biomark Med, 2012.6(4): p. 431-9.
  • 6Quigley, H., S.J. Colloby, and J.T. O'Brien, PET imaging of brain amyloid in dementia: a review. Int J Geriatr Psychiatry, 2011.26(10): p. 991-9.
  • 7Nord, M. and L. Farde, Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci Ther, 20 l 1.17(2): p. 97-103.
  • 8Johnson, S., et al., The reduction of RI, a novel repressor protein for monoamine oxidase A, in major depressive disorder. Neuropsyehopharmacology, 2011.36(10): p. 2139-48.
  • 9Nikolaus, S., et al., Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders-results from in vivo imaging studies. Rev Neurosci, 2010.21(2): p. 119-39.
  • 10Jones, T. and E.A. Rabiner, The development, past achievements, and future directions of brain PET. J Cereb Blood Flow Metab, 2012.32(7): p. 1426-54.

二级参考文献96

  • 1朱大年.神经系统功能活动的基本原理//姚泰.生理学.北京:人民卫生出版社,2005:410-411.
  • 2胡刚.镇静催眠药//杨世杰.药理学.北京:人民卫生出版社.2005:196-197.
  • 3Olsen RW, Sieghart W. GABAA receptors: Subtypes provide diver- sity of function and pharmacology. Neuropharmacology, 2009, 56 (1): 141-148.
  • 4Luddens H, Seeburg PH, Korpi ER. Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. Mol Pharmacol, 1994, 45(5 ): S10-814.
  • 5Wingrove PB, Wafford KA, Bain C, et al. The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit. Proc Natl Acad Sci USA, 1994, 91 ( 10 ): 4569-4573.
  • 6Korpi ER, Kuner T, Seeburg PH, et al. Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor. Mol Pharmacol, 1995, 47( 2 ): 283-289.
  • 7Pirker S, Schwarzer C, Wiesehhaler A, et al. GABA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience, 2000, 101(4): 815-850.
  • 8Uusi-Oukari M, Korpi ER. Regulation of GABAA receptor subunit expression by pharmacological agents. Pharmacol Rev, 2010, 62 ( 1 ): 97-135.
  • 9Yee BK, Keist R, yon Boehmer L, et al. A schizophrenia-related sensorimotor deficit links containing GABAA receptors to a dopamine hyperfunction. Proc Natl Acad Sci USA, 2005, 102 (47): 17154-17159.
  • 10Smith SS, Gong QH, Hsu FC, et al. GABA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature, 1998, 392( 6679 ): 926-930.

共引文献6

同被引文献18

引证文献3

二级引证文献11

中国医疗器械信息
2013年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部